切换至 "中华医学电子期刊资源库"

中华胃肠内镜电子杂志 ›› 2021, Vol. 08 ›› Issue (01) : 13 -17. doi: 10.3877/cma.j.issn.2095-7157.2021.01.002

所属专题: 文献

论著

结直肠癌合并高风险性腺瘤内镜治疗时机的临床研究
李晓景1, 高孝忠2,(), 褚衍六2, 孙建明3, 刘奉2, 宋军伟3   
  1. 1. 256622 山东滨州,滨州医学院;255120 山东淄博,淄博矿业集团有限责任公司中心医院
    2. 256622 山东滨州,滨州医学院
    3. 255120 山东淄博,淄博矿业集团有限责任公司中心医院
  • 收稿日期:2020-10-13 出版日期:2021-02-15
  • 通信作者: 高孝忠

Clinical study on the timing of endoscopic therapy for colorectal cancer combining with high-risk adenoma

Xiaojing Li1, Xiaozhong Gao2,(), Yanliu Chu2, Jianming Sun3, feng Liu2, Junwei Song3   

  1. 1. Clinical College of Binzhou Medical College. Binzhou 256622, China; Central Hospital of Zibo Mining Group Co., Ltd. Zibo 255120, China
    2. Clinical College of Binzhou Medical College. Binzhou 256622, China
    3. Central Hospital of Zibo Mining Group Co., Ltd. Zibo 255120, China
  • Received:2020-10-13 Published:2021-02-15
  • Corresponding author: Xiaozhong Gao
引用本文:

李晓景, 高孝忠, 褚衍六, 孙建明, 刘奉, 宋军伟. 结直肠癌合并高风险性腺瘤内镜治疗时机的临床研究[J]. 中华胃肠内镜电子杂志, 2021, 08(01): 13-17.

Xiaojing Li, Xiaozhong Gao, Yanliu Chu, Jianming Sun, feng Liu, Junwei Song. Clinical study on the timing of endoscopic therapy for colorectal cancer combining with high-risk adenoma[J]. Chinese Journal of Gastrointestinal Endoscopy(Electronic Edition), 2021, 08(01): 13-17.

目的

针对结直肠癌合并高风险性腺瘤可择期外科手术的患者,探讨内镜下治疗的合适时机。

方法

收集2013年1月至2018年6月经山东省威海市立医院诊治结直肠癌合并高风险性腺瘤的患者88例,将患者分为二组。A组52例患者,伴发高风险性腺瘤共96枚,该组患者先行结直肠癌外科手术,术后半年内行内镜下高风险性腺瘤治疗;B组36例患者,伴发高风险性腺瘤共54枚,该组患者先行结直肠高风险性腺瘤内镜下治疗,1~2周后再行结直肠癌外科手术治疗。分别记录患者的术前情况,手术相关情况,术后3~36个月随访结肠镜检查、肿瘤复发情况。

结果

A组患者外科术后切除腺瘤,其中4例患者腺瘤发生癌变,均行二次外科手术进行切除、另4例患者出现吻合口复发,行二次外科手术。B组患者术前腺瘤切除术中1例出现穿孔,行外科区段切除手术,另有2例术后病理亦为腺瘤癌变侵及黏膜下层>1 000 μm,行外科区段切除手术,术后复查未发现吻合口复发。两组患者二次外科手术发生率对比有统计学意义(P<0.001)。

结论

针对结直肠癌合并高风险性腺瘤可择期外科手术的患者,先行内镜治疗结直肠腺瘤,1~2周后再行结直肠癌外科手术,可有效减少二次外科手术的发生,值得临床广泛推广。

Objective

To explore the appropriate time of endoscopic treatment for colorectal cancer patients with high-risk adenomawho could be operated on electively.

Methods

A total of 88 patients with colorectal cancer complicated with high-risk adenoma in Weihai Municipal Hospital from January 2013 to June 2018 were collected and divided into two groups.There were 52 patients in group A, with 96 high-risk adenomas. Patients in this group underwent surgery for colorectal cancer first, and endoscopic treatment for high-risk adenomas within six months after the operation; There were 36 patients in group B, with 54 high-risk adenomas. Patients in this group were first treated with colorectal high-risk adenomas under endoscopic treatment, and then received surgical treatment for colorectal cancer 1 to 2 weeks later. And record the patient's preoperative condition, surgery-related condition, Colonoscopy and tumor recurrence were followed up 3-36 months after operation.

Results

In group A, the adenoma was resected after surgery, among which 4 patients developed cancerous adenomas and underwent secondary surgical resection.The other 4 patients had anastomotic recurrence and underwent secondary surgery. In group B, 1 case of perforation occurred during adenoma resection. and surgical section resection was performed, the other 2 cases also showedthe adenoma became cancerous and submucosa >1 000 μm, and underwent surgical segmental resection, and no recurrence of anastomotic stoma was found in postoperative reexamination. The incidence of secondary surgical operations between the two groups was statistically significant (P<0.001).

Conclusion

For patients with colorectal cancer combined with high-risk adenomas that can be surgically operated on, endoscopic treatment of colorectal adenomas first and colorectal cancer surgery 1 to 2 weeks latercan effectively reduce the occurrence of secondary surgical operations, is worthy of widespread clinical promotion.

表1 腺瘤大小对比[n(%)]
表2 腺瘤发生部位对比[n(%)]
表3 腺瘤高风险特征对比[n(%)]
表4 腺瘤病理类型对比[n(%)]
图1 直肠低分化腺癌并横结肠高风险性腺瘤
图2 直肠低分化腺癌并升结肠高风险性腺瘤
[1]
申玉翠,徐建华,高鹏.内镜黏膜下剥离术治疗早期结直肠癌及癌前病变的回顾性分析[J].实用医学杂志,2020,36(13):1857-1860.
[2]
Oines M, Helsingen LM, Bretthauer M, et al. Epidemiology and risk factors of colorectal polyps[J]. Best Pract Res Clin Gastroenterol, 2017, 31(4): 419-424.
[3]
许俊,盛剑秋.结直肠癌筛查及其进展[J].胃肠病学,2020,25(1):1-6.
[4]
翟爱军,陈洪,张续乾.结直肠进展期腺瘤危险因素分析[J].中华保健医学杂志,2018,20(2):102-104.
[5]
Bretthauer M, Kaminski MF, Loberg M, et al.Population-based colonoscopy screening for colorectal cancer;a randomized clinical trial[J]. JAMA Intern Med, 2016, 176 (7): 894-902.
[6]
Morson BC.Evolution of cancer of the colon and rectum r[J]. Cancer, 1 974, 34(3): 845-849.
[7]
李文坤,吴静,刘揆亮.结肠镜新技术对结直肠病变检出水平影响的研究进展[J].胃肠病学和肝病学杂志,2019,28(9):1045-1050.
[8]
计敏,赵晓雷,胡海军.原发性结直肠癌1092例5年回顾性分析[J].广州医科大学学报,2017,45(3):40-44.
[9]
余英豪,姚梅宏. 结直肠息肉筛查与监测新进展[J].实用肿瘤杂志,2015, 30(2):101-104.
[10]
龙思丹,孙希珍,赵栋燕.肠息肉病因学相关性研究进展[J].医学综述,2020,26(14):2728-2732.
[11]
宋洁菲,盛剑秋.结肠镜检查和息肉切除术后随访策略进展[J].胃肠病学,2015,20(7):424-427.
[12]
刘宇虎,李志坚,袁燕文.早期结直肠癌内镜治疗效果、安全性及长期随访[J].现代消化及介入诊疗,2017,22(2):186-190.
[13]
Moussata D, Boschetti G, Chauvenet M, et al. Endoscopic and histologic characteristics of serrated lesions[J]. World J Gastroenterol, 2015, 10(21): 2896-2904.
[14]
杨路路,苟思琪,王劲松.结直肠腺癌中差分化细胞群的临床病理意义[J].中华病理学杂志,2019,48(4):276-281.
[15]
Waldmann, ElisabethHeinze, Georg, et al. Risk factors cannot explain the higher prevalence rates of precancerous colorectal lesions in men[J]. Br J Cancer, 2016, 115(11): 1421-1429.
[16]
李倩倩,王军,赵越.结直肠息肉发生相关危险因素的研究现状[J].医学综述,2020,26(16):3196-3200.
[17]
闫志辉,崔立红,浦江.结直肠癌及肠道腺瘤性息肉患者肠道菌群失调情况及相关危险因素分析[J].解放军医药杂志,2017, 29(5):25-29.
[1] 古丽米拉·亚森江, 阿依努尔·艾尔肯, 李佳隆, 郭强, 蒋铁民, 吐尔干艾力·阿吉. 胆囊切除术后胆管损伤不同治疗方式的疗效分析[J]. 中华普通外科学文献(电子版), 2023, 17(04): 262-266.
[2] 赖华健, 钟文文, 郭强, 李俊涛, 张翼飞, 叶雷, 马波, 尧冰, 瞿虎, 邱剑光, 王德娟. 二次腹腔镜肾盂成形术治疗肾盂输尿管连接部梗阻疗效分析[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(03): 228-232.
[3] 吴骏超, 和术臣, 王海峰, 王家平, 邱学德. 输尿管软镜与经皮肾镜治疗有经皮肾镜手术史的复杂性结石的比较[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(03): 233-236.
[4] 彭国兵, 费建平. 影响患者永久性结肠造口的状况及因素[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(03): 264-268.
[5] 陈润芝, 杨东梅, 徐慧婷. 信迪利单抗联合索凡替尼后线治疗MSS型BRAF突变的转移性结肠癌:个案报道并文献复习[J]. 中华结直肠疾病电子杂志, 2023, 12(05): 431-435.
[6] 鄂一民, 孙司正, 范小彧, 喻春钊. 结直肠癌粪便筛查的现状与展望[J]. 中华结直肠疾病电子杂志, 2023, 12(04): 331-336.
[7] 王小娜, 谭微, 李悦, 姜文艳. 预测性护理对结直肠癌根治术患者围手术期生活质量、情绪及并发症的影响[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 525-529.
[8] 梁文龙, 曹杰, 黄庆, 林泳, 黄红丽, 杨平, 李冠炜, 胡鹤. 信迪利单抗联合瑞戈非尼治疗晚期结直肠癌的疗效与安全性分析[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 409-413.
[9] 刘代江, 蒋俊艳, 万晓强, 马莎英. 结直肠癌肝转移患者生存状况及预后影响因素分析[J]. 中华消化病与影像杂志(电子版), 2023, 13(05): 284-288.
[10] 王健, 赵海剑, 孙静, 张晓雨, 陈柏羽. LncRNA SNHG4表达与结直肠癌预后的关系[J]. 中华消化病与影像杂志(电子版), 2023, 13(03): 139-144.
[11] 李永胜, 孙家和, 郭书伟, 卢义康, 刘洪洲. 高龄结直肠癌患者根治术后短期并发症及其影响因素[J]. 中华临床医师杂志(电子版), 2023, 17(9): 962-967.
[12] 王飞飞, 王光林, 孟泽松, 李保坤, 曹龙飞, 张娟, 周超熙, 丁源一, 王贵英. 敲低IMPDH1对结肠癌SW480、HT29细胞生物功能的影响[J]. 中华临床医师杂志(电子版), 2023, 17(08): 884-890.
[13] 孔凡彪, 杨建荣. 肝脏基础疾病与结直肠癌肝转移之间关系的研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(07): 818-822.
[14] 王亚丹, 吴静, 黄博洋, 王苗苗, 郭春梅, 宿慧, 王沧海, 王静, 丁鹏鹏, 刘红. 白光内镜下结直肠肿瘤性质预测模型的构建与验证[J]. 中华临床医师杂志(电子版), 2023, 17(06): 655-661.
[15] 王延召, 牛鹏飞, 丁长民, 高庆坤, 高兆亚, 安柯, 翟志超, 曾庆敏, 黄文生, 雷福明, 顾晋. 结直肠癌致腹壁巨大缺损的一期修补经验(附13例报告)[J]. 中华临床医师杂志(电子版), 2023, 17(05): 557-561.
阅读次数
全文


摘要